x
Breaking News
More () »

Implant procedure for PAD performed at UnityPoint Health in Bettendorf

The procedure took place on Wednesday, April 17 at the Bettendorf hospital performed by Dr. Nicolas W. Shammas.

BETTENDORF, Iowa — Editor's Note: The video above describes UnityPoint Health expanding its virtual healthcare options into Illinois.

On April 17, UnityHealth Point Bettendorf announced the first implant procedure for a new treatment for those with peripheral arterial disease (PAD) was performed at the hospital. 

Dr. Nicolas W. Shammas, MD, MS, Cardiovascular Medicine, PLLC, and Founder and Director of the Midwest Cardiovascular Research Foundation performed the the procedure. 

The patient is involved in a global study to expand treatment options for patients with PAD. The implant is designed to treat patients with symptomatic, limiting PAD who have failed conservative management. The study includes 315 patients across multiple sites in the United States, Europe, Australia, and New Zealand, patients will be monitored for 36 months.

“We take to heart our mission as the region’s established leader in heart care and prevention,” says Kathy Pulley, director of cardiology services at UnityPoint Health – Trinity. “Heart care patients in our region trust us for their care – before, during and after a heart event. Our team brings patients the cutting-edge care they expect right here at home.”

Peripheral arterial disease, or PAD, is a common condition in which narrowed arteries reduce blood flow to the arms and legs. It’s primarily caused by the buildup of fatty plaque in the arteries. PAD can happen in any blood vessel, but it’s more common in the legs than the arms. PAD affects more than 18 million Americans and more than 236 million people worldwide.

“UnityPoint Health is proud to offer a nationally recognized heart center, with patient outcomes that meet or exceed national standards,” says Pulley. “Having access to groundbreaking studies and new technologies is just one way we’re serving our community as the Quad Cities heart hospital.”

Trinity Heart Center is still looking for patients with symptomatic peripheral arterial disease in the Quad Cities to participate in the study. If interested, call Trinity Heart Center at (309) 779-5340, or visit UnityPoint Health.

► Download the WQAD News 8 App 
► Subscribe to our newsletter 
► Subscribe to our YouTube channel

Watch more news, weather and sports on News 8's YouTube channel

Before You Leave, Check This Out